← Back to All Stocks
ALX Oncology Holdings Inc. (ALXO) Analysis
Generated on: 2025-07-31 12:23:56 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
Analysis Values
Current Price
$0.53
Predicted Price
$0.69
Expected Return
12.87%
Confidence Score
0.86
RSI (14)
64.97
MACD
0.03
Volume
569,700
Float Shares
31,335,298
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
250
ALXO
ALX Oncology Holdings Inc.
12.87%
Price: $0.53
Confidence: 0.86
News
Low Float
Last updated: 2025-07-31 12:23:56
Technical Analysis
RSI: 64.97
MACD: 0.03
Risk Analysis
Volatility
105.81%
Max Drawdown
-85.8%
Beta
1.0
Risk Score
96.6
Social Sentiment
0
Social Sentiment Score (0-100)
Recent News
ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials
Clinical Trials Arena - 2025-04-28 11:51
Despite the failures, ALX Oncology remains hopeful about evorpacept and is focusing on combination trials with other anti-cancer antibodies.
Reddit Discussions
No recent Reddit discussions found.
Recent SEC Filings
No recent SEC filings found.
